Aleva secures a CE mark and $8 million

Aleva secures a CE mark and $8 million

17.12.2019 – Aleva Neurotherapeutics’ flagship product, the directSTIM Deep Brain Stimulation System for neurological indications such as Parkinson’s disease and essential tremor is now CE Mark certified. The company has also raised USD 8 million in the first closing of a Series E financing round.

Read more…